Dr Pothuri on the Phase 3 NRG-GY018 and RUBY Trials in Endometrial Cancer
Bhavana Pothuri, MD, discusses the phase 3 NRG-GY018 and RUBY trials in patients with endometrial cancer.
Source: onclive.com
Page 2 - Ruby Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ruby Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ruby Trial Today - Breaking & Trending Today
KEYNOTE-775: Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer
The expert panel reviews the KEYNOTE-775 trial, which focused on lenvatinib and pembrolizumab in advanced endometrial cancer.
Source: onclive.com
Dr Mirza on the FDA Approval of Dostarlimab Plus Chemotherapy in dMMR/MSI-H Endometrial Cancer
Mansoor Raza Mirza, MD, discusses the significance of the FDA approval of dostarlimab in combination with chemotherapy in patients with mismatch repair–deficient or microsatellite instability–high endometrial cancer.
Source: onclive.com
Recently Presented Data on Endometrial Cancer
The expert panel switches its focus to endometrial cancer and discusses recent data from clinical trials.
Source: onclive.com
NRG-GY018 and RUBY Trials in Endometrial Cancer
Experts on endometrial cancer review the NRG-GY018 and RUBY clinical trials.
Source: onclive.com